Thus, alterations in plasma MMP-9 and TIMP-1 levels are related to a pathological remodeling of target organs as heart, vessels, or kidney during the development of diabetic nephropathy, albuminuria, arterial stiffness, or hypertension (16, 19–21), among other pathological situations. This evidence concerns the gene MMP9 and Hypertension.